Source comparison
Ipamorelin vs Tesamorelin Which Better Comparison
Mechanism GHSR-1a agonist (ghrelin receptor). Triggers pulsatile GH release GHRH receptor agonist. Produces sustained GH elevation for 2–3 hours Ipamorelin mimics natural GH pulses; tesamorelin creates pharmacologic elevation Primary Application Body recomposi
This comparison does not assign a generated winner or score.
- Mechanism
- GHSR-1a agonist (ghrelin receptor). Triggers pulsatile GH release
- GHRH receptor agonist. Produces sustained GH elevation for 2–3 hours
- Ipamorelin mimics natural GH pulses; tesamorelin creates pharmacologic elevation
- Primary Application
- Body recomposition, lean mass retention, recovery optimization
- Visceral fat reduction in lipodystrophy; metabolic correction
- Tesamorelin has FDA approval for one specific indication; ipamorelin used broadly in research
- Dosing Frequency
- 2–3 times daily (200–300 mcg per dose)
- Once daily (2mg)
- Ipamorelin requires stricter scheduling; tesamorelin simplifies compliance
- Side Effect Profile
- Minimal. No cortisol or prolactin elevation, occasional transient flushing
- Injection site reactions, peripheral edema, glucose intolerance risk in predisposed patients
- Ipamorelin cleaner hormonally; tesamorelin carries metabolic monitoring requirements
- Visceral Fat Reduction
- Not demonstrated. GH pulses insufficient for sustained lipolysis
- 15.2% VAT reduction at 26 weeks (CT-verified, Phase 3 data)
- Tesamorelin objectively superior for visceral adiposity
- Lean Mass Preservation
- Supports nitrogen retention and protein synthesis during caloric deficit
- Not a primary outcome in clinical trials. Focus was fat reduction
- Ipamorelin better suited for maintaining muscle during fat loss
- Cost per Month (Typical Research Dose)
- ~$180–240 (600 mcg daily, small-batch synthesis pricing)
- ~$450–600 (2mg daily, higher synthesis cost due to 44-amino-acid structure)
- Tesamorelin significantly more expensive due to molecular complexity
- Post-Reconstitution Stability
- 28 days refrigerated in bacteriostatic water
- 3–5 days refrigerated in specialized diluent
- Ipamorelin allows batch preparation; tesamorelin requires frequent mixing
- Bottom Line
- Choose ipamorelin when the research goal is GH pulsatility restoration, body recomposition, or recovery enhancement without metabolic disruption. It's the cleaner, more versatile compound for non-pathological applications.
- Choose tesamorelin when visceral adiposity is the primary target and daily dosing logistics are manageable. It's the only peptide with Phase 3 evidence for VAT reduction and the only one FDA-approved for a GH-related indication.